The Department of Ayush, which regulates the estimated Rs 6,000-crore ayurveda, siddha and unani Indian Systems of Medicine (ISM), has initiated new licensing norms to weed out irrational patent and proprietary (P&P) medicines, which are innovated products not mentioned in classical texts of the ISM.
The department’s move comes close on the heels of the Drug Controller General of India’s attempts to weed out ‘irrational’ pharmaceutical formulations or innovated fixed-dose combinations (FDCs) of known chemical compounds combined not in accordance with pharmacopoeia standards.
Sharmaji is deeply involved with Ayurveda since 15 years. His interest and passion led him to launch AyurvedNews.com and AyurShop.in about a decade ago. Most of the Ayurveda news and articles on this site are approved or published by him.